The present invention provides a stable pharmaceutical composition comprising aripiprazole, crospovidone having peroxide content of less than 80 ppm, advantageously less than 50 ppm, and eventually other suitable pharmaceutically acceptable excipient, and its use in the treatment of schizophrenia, bipolar disorder, and clinical depression.